Who will survive when the COVID19 hype ends? Part II

Valeo Pharma has a strategy that any investor can understand, and the proof of concept is in their latest quarterly filings.

@valeo_pharma $VPH
#Biotech #Pharma #Medical #Investing $JNJ $HLS

https://t.co/7w0oKQ6uoT https://t.co/6JDOZqY9IU